# Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

> **NCT01962181** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 40 (estimated)

## Conditions studied

- "Attention Deficit Hyperactivity Disorder"

## Interventions

- **DRUG:** Ritalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01962181
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01962181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01962181, "Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01962181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*